Experience

Oncorx Pharmaceuticals, Inc.

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• President and Chief Scientific Officer

  • 2014 - Present

  Oncorx Pharmaceuticals is an early-stage pharmaceutical company developing high-affinity drugs that selectively target the P-glycoprotein/CD44 protein complex and the β1 protein subunit of α5β1 integrin that are overexpressed on the surface of therapy-resistant tumors. Activation of α5β1 integrin plays an important role in regulating cytoskeletal reorganization, F-actin polarization, the epithelial-to-mesenchymal transition, anchorage-independent tumor cell growth, and tumor cell apoptosis. (oncorxpharmaceuticals.com)



B&G Partners, Inc.

• President and Chief Scientific Officer

  • 2009 - Present



Procor Pharmaceuticals Inc.

• Co-founder, President and Chief Scientific Officer

  • 2005 - 2009



Barbeau Pharma Inc.

• Founder, Chief Scientific Officer and Director

  • 2000 - 2009



Biomega Corporation

• Founder and President

  • 1986 - 2000

  Biomega Corporation, was an intellectual property consulting firm that serviced the pharmaceutical, chemical, and emerging biotechnology companies during that period. In addition, Mr. Barbeau was the Editor-in-Chief of the company’s medical journal covering clinical trials on drugs emerging from phase III clinical studies. Biomega Corporation, was an intellectual property consulting firm that serviced the pharmaceutical, chemical, and emerging biotechnology companies during that period. In addition, Mr. Barbeau was the Editor-in-Chief of the company’s medical journal covering clinical trials on drugs emerging from phase III clinical studies.



American Hospital Supply Corporation

• Intellectual Property Manager

  • 1979 - 1986

  Managed or co-managed the patent programs of the company’s cardiovascular and clinical diagnostics business units, and assessed the strength of intellectual property for most of the company’s acquisitions during that period. Managed or co-managed the patent programs of the company’s cardiovascular and clinical diagnostics business units, and assessed the strength of intellectual property for most of the company’s acquisitions during that period.



University of Chicago in the Specialized Center of Research on Arteriosclerosis

• Senior Scientist

  • 1973 - 1979

  Research involved the assessment of protein-protein and protein-lipid interactions found in serum high density lipoproteins. Research involved the assessment of protein-protein and protein-lipid interactions found in serum high density lipoproteins.